Equity Profile

ADPT

Adaptive Biotechnologies Corporation

Health CareLife Sciences Tools & Services$3.9B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Adaptive Biotechnologies Corporation focuses on using the immune system to develop innovative diagnostics and therapeutics. As a player in the health care sector, particularly in life sciences tools and services, its work is crucial for advancing personalized medicine and understanding immune responses.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.10

Revenue

Revenue figures help gauge the company's sales performance and market demand for its products.

$72M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ADPT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+37.94%

Avg Stock Reaction

-0.91%

Last Quarter Recap

In Q1 2026, Adaptive Biotechnologies reported an EPS of $-0.13, which was better than the expected $-0.15, marking a positive surprise. However, revenue details were not disclosed, and the stock fell by nearly 5% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Adaptive Biotechnologies to report a loss of $0.10 per share on revenues of $72 million for Q2 2026. The market is closely watching how the company manages its growth and profitability amidst ongoing challenges.

Bull Case

If the company can exceed revenue expectations and show signs of improving its path to profitability, it could bolster investor confidence and drive the stock higher.

Bear Case

On the other hand, if the company fails to meet its revenue targets or provides weak guidance, it could lead to further declines in stock price.

Key Metrics to Watch

EPS

$-0.10

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$72M

Revenue figures help gauge the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company achieve revenue of at least $72 million?

This figure is crucial for assessing market demand and the company's growth trajectory.

What specific strategies are in place to reduce the EPS loss?

Understanding management's approach to improving profitability will be key for investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for revenue growth driven by new product launches and partnerships, which could significantly improve performance this quarter.

Supporting Evidence

The company's history of beating EPS estimates suggests they may outperform expectations again.

Options pricing indicates a higher volatility expectation than historical averages, hinting at potential surprises.

Recent developments in personalized medicine could drive unexpected demand for their services.

Key Risk

If revenue comes in below $70 million, it could challenge the entire growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the company's ability to balance growth with profitability, making these metrics pivotal.

Bull Confirmed If

Revenue exceeding $72 million with a clear path to reducing EPS losses.

Bear Confirmed If

Revenue falling below $70 million or a wider EPS loss than expected.

Pre-Earnings Positioning

Options Market

Implied Move

±37.62%

Historical Avg

±2.6%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±37.6% while ADPT has averaged ±2.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

53.6%

Calls (1K)P/C Ratio: 0.31Puts (400)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Adaptive exceeds expectations, history suggests a potential average move of +2.61%, confirming a positive outlook.

In-Line / Cautious

If results are in line but management is cautious, the stock may see muted reactions as investors reassess growth potential.

Miss

A miss on earnings could lead to a decline, with historical patterns indicating an average drop of around -4.97%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Details on cost management strategies to improve EPS.
3Insights into market demand for their diagnostic services.
4Management's outlook on competitive pressures in the life sciences sector.
5Any commentary on partnerships or collaborations that could enhance growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.10

Revenue

Revenue figures help gauge the company's sales performance and market demand for its products.

$72M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ADPT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+37.94%

Avg Stock Reaction

-0.91%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company can exceed revenue expectations and show signs of improving its path to profitability, it could bolster investor confidence and drive the stock higher.

Bear Case

On the other hand, if the company fails to meet its revenue targets or provides weak guidance, it could lead to further declines in stock price.

Key Metrics to Watch

EPS

$-0.10

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$72M

Revenue figures help gauge the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the company achieve revenue of at least $72 million?

This figure is crucial for assessing market demand and the company's growth trajectory.

What specific strategies are in place to reduce the EPS loss?

Understanding management's approach to improving profitability will be key for investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for revenue growth driven by new product launches and partnerships, which could significantly improve performance this quarter.

Supporting Evidence

The company's history of beating EPS estimates suggests they may outperform expectations again.

Options pricing indicates a higher volatility expectation than historical averages, hinting at potential surprises.

Recent developments in personalized medicine could drive unexpected demand for their services.

Key Risk

If revenue comes in below $70 million, it could challenge the entire growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the company's ability to balance growth with profitability, making these metrics pivotal.

Bull Confirmed If

Revenue exceeding $72 million with a clear path to reducing EPS losses.

Bear Confirmed If

Revenue falling below $70 million or a wider EPS loss than expected.

Pre-Earnings Positioning

Options Market

Implied Move

±37.62%

Historical Avg

±2.6%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±37.6% while ADPT has averaged ±2.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

53.6%

Calls (1K)P/C Ratio: 0.31Puts (400)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Adaptive exceeds expectations, history suggests a potential average move of +2.61%, confirming a positive outlook.

In-Line / Cautious

If results are in line but management is cautious, the stock may see muted reactions as investors reassess growth potential.

Miss

A miss on earnings could lead to a decline, with historical patterns indicating an average drop of around -4.97%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Details on cost management strategies to improve EPS.
3Insights into market demand for their diagnostic services.
4Management's outlook on competitive pressures in the life sciences sector.
5Any commentary on partnerships or collaborations that could enhance growth.